Buphenine
From Wikipedia, the free encyclopedia
(Redirected from Nylidrin)
![]() |
|
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | C04AA02 (WHO) G02CA02 (WHO) |
Identifiers | |
|
|
CAS Number | 447-41-6 |
PubChem (CID) | 4567 |
ChemSpider | 4407 |
UNII | 695DKH33EI ![]() |
ChEMBL | CHEMBL114655 ![]() |
ECHA InfoCard | 100.006.531 |
Chemical and physical data | |
Formula | C19H25NO2 |
Molar mass | 299.41 g/mol |
3D model (Jmol) | Interactive image |
|
Buphenine (or nylidrin) is a β2 adrenoreceptor agonist[1] that acts as a vasodilator.
See also[edit]
References[edit]
- ^ Mittag TW, Tormay A, Messenger M, Podos SM (February 1985). "Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin". Invest. Ophthalmol. Vis. Sci. 26 (2): 163–9. PMID 2857689.
![]() |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
![]() |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |